Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
103
NMPA:103
Drug Approvals
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20254072
- Approval Date
- May 13, 2025
NMPA
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20254071
- Approval Date
- May 13, 2025
NMPA
Ertapenem Sodium for Injection
- Product Name
- 注射用厄他培南钠
- Approval Number
- 国药准字H20253345
- Approval Date
- Feb 8, 2025
NMPA
Glucosamine Sulfate Capsules
- Product Name
- 硫酸氨基葡萄糖胶囊
- Approval Number
- 国药准字H20249696
- Approval Date
- Dec 6, 2024
NMPA
Fluvoxamine Maleate Tablets
- Product Name
- 马来酸氟伏沙明片
- Approval Number
- 国药准字H20249543
- Approval Date
- Dec 1, 2024
NMPA
Polyethylene Glycol Electrolytes Powder (III)
- Product Name
- 复方聚乙二醇电解质散(Ⅲ)
- Approval Number
- 国药准字H20249673
- Approval Date
- Dec 1, 2024
NMPA
Fluvoxamine Maleate Tablets
- Product Name
- 马来酸氟伏沙明片
- Approval Number
- 国药准字H20249544
- Approval Date
- Dec 1, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found